ClinConnect ClinConnect Logo
Search / Trial NCT06741332

Accelerating Referral for Thrombectomy in Acute Stroke Patients Using an Artificial Intelligence-based Software

Launched by HOSPITAL UNIVERSITARI VALL D'HEBRON RESEARCH INSTITUTE · Dec 16, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Stroke Ischemic Stroke Acute Stroke M Dido Artificial Intelligence

ClinConnect Summary

This clinical trial is looking at how an artificial intelligence (AI) software called Methinks Stroke Suite can help speed up the process of transferring patients who have had a stroke and need a specific treatment called thrombectomy. When someone has an acute ischemic stroke, they may need to be moved from a local hospital to a specialized center that can perform this treatment. The researchers want to find out if using this AI software can help doctors make quicker and more accurate decisions about whether a patient should be transferred for this procedure.

To participate in the study, individuals must be over 18 years old and suspected of having an acute stroke, with symptoms starting within the last 24 hours. Participants will have a CT scan at the local hospital, which the AI software will analyze. If the AI and the doctors agree that the patient may need thrombectomy, they will be transferred to a specialized center. After the transfer, the patients will be followed for 90 days to see how well they recover. The trial is currently recruiting participants, and it’s important to know that people in a coma or those needing immediate life support cannot take part in this study.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Suspected acute stroke patients
  • 2. \>18 years with no upper age limit
  • 3. Included \< 24 h since last seen well
  • 4. Non-contrast CT is available at the local stroke center
  • 5. Image has been processed by Methinks Stroke Suite
  • 6. Informed consent obtained from a patient or his or her legally designated representative (if locally required).
  • Exclusion Criteria:
  • 1. Patients in a coma (NIHSS item of consciousness \>1)
  • 2. Patients with unstable clinical status who require emergent life support care
  • 3. Subject imaging does not meet Image Acquisition and DICOM Tag Requirements

About Hospital Universitari Vall D'hebron Research Institute

The Hospital Universitari Vall d'Hebron Research Institute (VHIR) is a leading biomedical research center affiliated with Vall d'Hebron University Hospital in Barcelona, Spain. Committed to advancing healthcare through innovative research, VHIR focuses on translating scientific discoveries into clinical applications, enhancing patient care and outcomes. The institute fosters collaboration among multidisciplinary teams of researchers, clinicians, and industry partners, emphasizing excellence in translational medicine, clinical trials, and public health initiatives. With a strong emphasis on ethical standards and patient safety, VHIR is dedicated to contributing to the global body of knowledge in various medical fields.

Locations

Barcelona, , Spain

Granollers, Barcelona, Spain

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported